<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">Gates Open Res</journal-id>
            <journal-title-group>
                <journal-title>Gates Open Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2572-4754</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/gatesopenres.14326.1</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Research Article</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Benefits, anxieties, acceptance, and barriers to the new injectable contraceptive DMPA-SC (Sayana Press): Clients&#x2019; perceptions in Sindh, Pakistan</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 1; peer review: 1 approved with reservations, 1 not approved]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Veesar</surname>
                        <given-names>Ghulam Yaseen</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Software</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <uri content-type="orcid">https://orcid.org/0000-0003-0152-4204</uri>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Lashari</surname>
                        <given-names>Talib</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Fida</surname>
                        <given-names>Roshan</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Veesar</surname>
                        <given-names>Mansoor Ahmed</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a4">4</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Institute of Business Management, Karachi, Sindh, 75190, Pakistan</aff>
                <aff id="a2">
                    <label>2</label>Costed Implementation Plan (CIP)/FP2030, Unit, Population Welfare Department, Government of Sindh, Near Jinnah Hospital, Karachi, Sindh, 75510, Pakistan</aff>
                <aff id="a3">
                    <label>3</label>RIZ Consulting, Islamabad, Pakistan</aff>
                <aff id="a4">
                    <label>4</label>Behaviour Change Communication (BCC), Green Star Social Marketing, Karachi, Pakistan</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:yaseenveesar@yahoo.com">yaseenveesar@yahoo.com</email>
                </corresp>
                <fn fn-type="conflict">
                    <p>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>9</day>
                <month>5</month>
                <year>2023</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2023</year>
            </pub-date>
            <volume>7</volume>
            <elocation-id>66</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>14</day>
                    <month>4</month>
                    <year>2023</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2023 Veesar GY et al.</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://gatesopenresearch.org/articles/7-66/pdf"/>
            <abstract>
                <p>
                    <bold>Background:</bold> Injections are Pakistan's third most preferred contraceptive method because of their convenience. They represent a 2.5% share of the contraceptive prevalence rate (CPR) and contribute 10% to the current CPR. However, injections require a clinical setting or a healthcare provider for administration. A new method of subcutaneous presentation of depot medroxyprogesterone acetate (DMPA-SC), namely Sayana Press in Uniject&#x2122;, has been introduced, which can be administered in nonclinical settings or self-administered by trained women. This study examined clients&#x2019; perceptions of the current depot medroxyprogesterone acetate-intramuscular injection (DMPA-IM) and its accessibility, availability, affordability, advantages, and disadvantages. In addition, it explored the benefits, barriers, and challenges regarding the new method of DMPA-SC (Sayana Press), especially considering self-injection.</p>
                <p>
                    <bold>Methods:</bold> The study was conducted in Sindh, Pakistan. Three focus group discussions were conducted with 9&#x2013;13 female participants with different demographic characteristics. A semi-structured questionnaire was used. The discussion was recorded, transcribed, and translated from Urdu or Sindhi to English. Transcripts were coded precisely, and data analysis was performed using NVivo software.</p>
                <p>
                    <bold>Results:</bold>Participants expressed moderate fear of self-injection and risk of an inaccurate prick, suggesting that DMPA-SC acceptance may not be challenging at a community level. They appreciated free services at public health facilities, as the affordability of private facilities may be challenging for those with low income. Most participants agreed to pay PKR 50&#x2013;300 (approximately 1 USD or less) as service charges for a private facility, while some agreed to pay for transportation costs when lacking alternative methods.</p>
                <p>
                    <bold>Conclusions:</bold> DMPA-SC is a valuable alternative, provided its challenges are adequately addressed. Information about self-injection contraceptives is currently limited, and shared self-administration may be difficult without adequate training and counseling. Nevertheless, clients prefer the self-injection method for family planning to avoid transportation and private service charges.</p>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>Contraceptive</kwd>
                <kwd>DMPA-SC</kwd>
                <kwd>Sayana Press</kwd>
                <kwd>Injectable</kwd>
                <kwd>Sindh</kwd>
                <kwd>Pakistan</kwd>
                <kwd>Women</kwd>
                <kwd>Perception</kwd>
            </kwd-group>
            <funding-group>
                <award-group id="fund-1" xlink:href="http://dx.doi.org/10.13039/100000865">
                    <funding-source>Gates Foundation</funding-source>
                    <award-id>ICFP2022</award-id>
                </award-group>
                <funding-statement>This research was presented at the International Conference on Family Planning 2022, supported by the Gates Foundation [ICFP2022]. The authors declared that no other grants were involved in supporting this work.</funding-statement>
                <funding-statement>
                    <italic>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</italic>
                </funding-statement>
            </funding-group>
        </article-meta>
    </front>
    <body>
        <sec sec-type="intro">
            <title>Introduction</title>
            <p>Pakistan has the fifth-highest population worldwide, with 207 million people
                <sup>
                    <xref ref-type="bibr" rid="ref-1">1</xref>
                </sup>. The rising trend of population growth has continued since the country&#x2019;s independence. Subsequently, family planning (FP) programs were introduced by a non-government organization, the Family Planning Association of Pakistan (FPAP). However, during the regime of General Ayoub Khan, the government officially included FP as a program in the national policy and planning during the second five-year plan (1960&#x2013;65)
                <sup>
                    <xref ref-type="bibr" rid="ref-2">2</xref>
                </sup>. Nevertheless, approximately 60 years after the program&#x2019;s inception, Pakistan&#x2019;s contraceptive prevalence rate (CPR) has not significantly increased. It remained almost static for 10 years, at 34%. The demand for FP remains high in Pakistan: four million (17%) married women of reproductive age have not yet received FP services. According to the Pakistan Demographic and Health Survey (PDHS) 2017&#x2013;18, the total demand for FP is 52% among married women of reproductive age (MWRA); eight million (34.2%) MWRA are currently using FP methods, among whom approximately six million (25%) MWRA are using modern methods, whereas the remaining 9% are using traditional FP methods. Male condoms (9.2%) and female sterilization (8.8%) are the most common methods, encompassing 72% of the modern contraceptive prevalence rate. Injection (2.5%) is the third most popular method of FP among women using modern contraceptives, with a higher rate than the long-term method of an intrauterine contraceptive device (2.1%). It makes up 10% of the modern CPR
                <sup>
                    <xref ref-type="bibr" rid="ref-3">3</xref>
                </sup>.</p>
            <p>The current injection method, depot medroxyprogesterone acetate-intramuscular injection (DMPA-IM), has limited service access, as it requires a clinical setting or the assistance of a trained healthcare service provider to deliver this method of contraception
                <sup>
                    <xref ref-type="bibr" rid="ref-4">4</xref>
                </sup>. The subcutaneous presentation of DMPA (Sayana Press) is a 104-mg single dose of medroxyprogesterone acetate in 0.65-ml volume, sterilely packaged in the Uniject&#x2122; device. Uniject&#x2122; is a pre-filled, non-reusable blister injection system comprising a bubble reservoir with an integral, ultra-thin needle, believed to be a notable advancement in the field
                <sup>
                    <xref ref-type="bibr" rid="ref-5">5</xref>
                </sup>. It has several features that add advantages to the new injectable method. Community health workers, for example, female health and family welfare workers or women desiring to inject a contraceptive themselves after training, can administer it in nonclinical settings. Accepting Uniject&#x2122; as a self-injection can meet demand in all situations, particularly when access is restricted because of natural disasters, during public health emergencies such as the coronavirus disease 2019, and for remote administration under the self-care model. After the stipulated training, female clients can easily self-administer the injection with complete privacy. The product&#x2019;s shelf life is also adjustable following Pakistan&#x2019;s climate conditions and can be easily stored at an average room temperature (15&#x2013;30&#x00b0;C).</p>
            <p>The Sayana Press summary of product characteristics, under &#x201c;Section 4.8 Undesirable effects,&#x201d; states that commonly reported injection-site reactions include persistent injection-site atrophy, indentation, or dimpling; injection-site nodules or lumps; and injection-site pain or tenderness (occurring in &#x2265; 1/100 to &lt; 1/10 cases). Lipodystrophy (acquired) is rarely reported (occurring in &#x2265; 1/10 000 to &lt; 1/1000 cases) in patients receiving subcutaneous DMPA (DMPA-SC)
                <sup>
                    <xref ref-type="bibr" rid="ref-6">6</xref>
                </sup>. According to Pfizer Limited, the product&#x2019;s manufacturer, evidence suggests a minute increased risk of cardiovascular events among women with hypertension or lipid disorders who used progestogen-only injectables. If hypertension occurs during Sayana Press administration or its increase cannot be adequately controlled using antihypertensive medication, its administration is risky. Additional risk factors for arterial thrombotic disorders include hypertension, smoking, age, lipid disorders, migraine, obesity, positive family history, cardiac valve disorders, and atrial fibrillation
                <sup>
                    <xref ref-type="bibr" rid="ref-7">7</xref>
                </sup>. The company also claimed that patients with the above risk factors should use the Sayana Press method cautiously.</p>
            <p>The Sayana Press is a new contraceptive method in its inception phase in Pakistan, with support from the public sector in Sindh province. Initially, Sayana Press was discussed in the costed implantation plan (CIP) regarding FP for Sindh in 2015 for its introduction and implantation
                <sup>
                    <xref ref-type="bibr" rid="ref-8">8</xref>
                </sup>. DMPA-SC (Sayana Press) was introduced in Sindh, Pakistan, in 2019 after a randomized control trial comprehensive study
                <sup>
                    <xref ref-type="bibr" rid="ref-9">9</xref>
                </sup> provided evidence that lady health workers can safely and effectively administer injectable contraception, including DMPA-IM and DMPA-SC, to their clients after training. The CIP unit of the population welfare department, the Government of Sindh, with help from RIZ Consulting, also conducted a pilot study on DMPA-SC self-injection
                <sup>
                    <xref ref-type="bibr" rid="ref-10">10</xref>
                </sup>. Considering its results, the Government of Sindh developed a rollout plan for self-injection through its CIP. Sayana Press can pave a significant trajectory for modern FP methods with self-injection features because it provides safety and ease of subcutaneous injection use. Like the Government of Sindh, health and FP ministries of other countries, for example, Nigeria and Senegal, have enacted policies allowing community health workers to administer the product and even permit drug stores and shopkeepers to engage in direct sales
                <sup>
                    <xref ref-type="bibr" rid="ref-11">11</xref>
                </sup>. This product, which expands the availability of contraceptives, can increase FP services, specifically in communities where access to FP services, especially injectables, is limited. The government&#x2019;s and donor agencies&#x2019; efforts to increase the use of Sayana Press show its impact. However, understanding of Sayana Press is limited, specifically regarding client perceptions. Sayana Press has new self-injection features. Therefore, learning about clients&#x2019; experiences and perceptions regarding this change is crucial. Hence, this study addresses this deficit by collecting insights from end users.</p>
        </sec>
        <sec>
            <title>Study aims</title>
            <p>The study primarily aimed to gain insight from clients to understand women&#x2019;s perceptions of the current form of injection (administered by a trained healthcare provider) and the new injection method DMPA-SC, considering the objectives given below:</p>
            <list list-type="bullet">
                <list-item>
                    <label>&#x25aa; </label>
                    <p>Obtain clients&#x2019; perspectives regarding the current contraceptive injection (DMPA-IM) use, considering accessibility, availability, affordability, advantages, and disadvantages.</p>
                </list-item>
                <list-item>
                    <label>&#x25aa; </label>
                    <p>Obtain clients&#x2019; perceptions regarding the new method of DMPA-SC as self-injection, considering benefits, fears regarding self-injecting, potential challenges or barriers that clients face, and their perceptions of Uniject&#x2122;, especially concerning self-injection.</p>
                </list-item>
            </list>
        </sec>
        <sec sec-type="methods">
            <title>Methods</title>
            <sec>
                <title>Ethical considerations</title>
                <p>This study received ethical approval from the Research Ethics Review Committee, Health and Hospital Management Program, Institute of Business Management, Karachi (IRB no. 20161&#x2013;21588; approved on March 10
                    <sup>th</sup> 2021). The researcher informed the participants about the research objectives in their native language, and verbal consent for participation and data publication was obtained before proceeding to the discussion. After their consent was obtained, which the interviewer recorded in interview forms, the discussion was recorded for future transcription. The respondents of the study belonged to different demographic backgrounds (geographical Rural, Urban, and education) and participants did not want to disclose their identity in any way. Verbal consent was approved by the Research Ethics Review Committee.</p>
            </sec>
            <sec>
                <title>Study design</title>
                <p>This qualitative study used the focus group discussion (FGD) method by adopting a purposive sample technique instead of a statistically representative sample of a broader population
                    <sup>
                        <xref ref-type="bibr" rid="ref-11">11</xref>
                    </sup> to gain an in-depth understanding of social issues. FGD serves to solicit information regarding participants&#x2019; attitudes and perceptions, knowledge and experiences, and practices shared during interactions with different people. The technique assumes that during FGD, group dynamics will be activated to help identify and clarify shared knowledge among group members, which would otherwise be challenging to obtain through individual interviews
                    <sup>
                        <xref ref-type="bibr" rid="ref-12">12</xref>
                    </sup>. Participants were recruited following the guidance in &#x201c;How to conduct FGD Methodological Manual&#x201d; by Peter van Eeuwijk and Zuzanna Angehrn
                    <sup>
                        <xref ref-type="bibr" rid="ref-12">12</xref>
                    </sup>. Furthermore, they were recruited according to the inclusion criteria of being married, with the help of social mobilizers providing FP services in these areas. The number of participants was finalized considering the manual
                    <sup>
                        <xref ref-type="bibr" rid="ref-12">12</xref>
                    </sup>, and in each FGD, 9&#x2013;13 women with different demographic characteristics, including education, parity, profession, and age, were included. According to a previous study, three FGDs are sufficient to reach saturation of codes
                    <sup>
                        <xref ref-type="bibr" rid="ref-13">13</xref>
                    </sup>. Hence, three FGDs were conducted for this study.</p>
                <p>The Government of Sindh introduced Sayana Press DMPA-SC in a few selected districts. The selection of areas for study from districts (Karachi, Hyderabad, and Sukkur) was intended to ensure adequate representation of urban and rural participation. The FGDs were conducted using a semi-structured field guide comprising an open-ended questionnaire developed through available literature. Its contents and face validity were evaluated, and a pilot test was performed through an internal testing process, as outlined by DeVon 
                    <italic toggle="yes">et al.</italic>
                    <sup>
                        <xref ref-type="bibr" rid="ref-14">14</xref>
                    </sup>. First, the tool kit was finalized in English. It was then translated into Urdu and Sindhi. Considering cultural constraints, female data collectors with expertise in the above languages were engaged to conduct FGDs, during which they encouraged respondents to participate in the study. The participants were recruited with help from field workers during the last week of March 2021 at three sites, and data were collected and completed from April to May 2021. The researchers informed the participants about the research objectives in their native language and obtained their consent before proceeding to the discussion. After their consent was obtained, the discussion was recorded for future transcription. The total duration of all three FGDs was 143 minutes (not including the general introduction and rapport-building process, which were not recorded). The audio was initially transcribed in the original recorded language (Sindhi and Urdu) and later translated into English and cross-checked by professional linguists.</p>
                <p>The researchers used the guidelines by Braun and Clark
                    <sup>
                        <xref ref-type="bibr" rid="ref-15">15</xref>
                    </sup> and followed the following six defined steps:</p>
            </sec>
            <sec>
                <title>Stage 1: Familiarity with the data</title>
                <p>The guidelines indicate that the researcher should become familiar with the dataset before starting the analysis. In the current study, the researchers had direct experience in the FP field and belonged to the local community. In this case, having a substantial understanding of the subject and the language used by the respondents was ensured. The researchers repeatedly read the transcripts and listened to the audio recordings to understand the responses in-depth.</p>
            </sec>
            <sec>
                <title>Stage 2: Generating initial codes</title>
                <p>Following the guidance of Braun and Clark
                    <sup>
                        <xref ref-type="bibr" rid="ref-15">15</xref>
                    </sup>, this study used a top-down method for developing initial codes aligned with the research questions and objectives, applying a deductive approach. Each data segment relevant to the research objectives was evaluated and assigned codes. Open coding was used and modified throughout the process. This strategy helped to clarify how participants provided feedback regarding their access to the FP services, especially concerning the DMPA-IM injection and the side effects or disadvantages of the injection method.</p>
            </sec>
            <sec>
                <title>Stage 3: Preparing themes</title>
                <p>Generally, themes are patterns relevant and notable to the research objectives. As Braun and Clarke provided no specific rules for themes except for using the nearest associations, this study created two major themes, considering the comparison between the two injection methods, one each for DMPA-IM and DMPA-SC, and recorded the coding in each area. The details of the coding are provided in 
                    <xref ref-type="table" rid="T1">Table 1</xref>. This approach is used when a study is driven by research questions
                    <sup>
                        <xref ref-type="bibr" rid="ref-16">16</xref>
                    </sup>.</p>
                <table-wrap id="T1" orientation="portrait" position="anchor">
                    <label>Table 1.</label>
                    <caption>
                        <title>Details of the themes and codes.</title>
                        <p>FP, family planning; DMPA, depot medroxyprogesterone acetate; IM, intramuscular injection; SC, subcutaneous; LHW, lady health workers; NGO, Non-Government Organization; LHV, lady health visitors.</p>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Theme 01</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Theme 02</th>
                            </tr>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Clients&#x2019; perspectives on FP services, especially DMPA-IM</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Perspectives on the new product (DMPA-SC)</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Codes:
                                    <break/>LWH Workers provide the injections
                                    <break/>We get it from civil hospital
                                    <break/>NGO clinic is near
                                    <break/>Baji (LHV) clinic is in our area
                                    <break/>We use the bus
                                    <break/>I need money for transportation
                                    <break/>Need transportation cost for another person who will accompany
                                    <break/>me
                                    <break/>Unable to feed family
                                    <break/>I work in the fields for our livelihood
                                    <break/>We do domestic labor
                                    <break/>We cannot afford the cost
                                    <break/>Poverty is the main problem
                                    <break/>Unable to buy dress, notebook, and pen for children
                                    <break/>Bleeding after injection
                                    <break/>Pain in my arm after injection
                                    <break/>Unable to use a hand pump
                                    <break/>Feeling weak after having injections
                                    <break/>Only 10 days are free from blood
                                    <break/>Continuous bleeding
                                    <break/>Government is free
                                    <break/>It is a sin; Allah (God) will give us a child
                                    <break/>Baji (LHV) clinic is good
                                    <break/>No rush in a private clinic
                                    <break/>Did not discuss this with her husband
                                    <break/>The government facility is far; we need transportation
                                    <break/>Sometimes return because of unavailability of stock
                                    <break/>It is hard to convince females about FP
                                    <break/>The injection is easier than pills
                                    <break/>Three months hassle-free method
                                    <break/>It is more economical than what we calculate for condoms
                                    <break/>No stock in government
                                    <break/>We receive good service in civil hospitals
                                    <break/>Discuss with husband, happy to use injection method
                                    <break/>Free product is not good
                                    <break/>We can pay service charges to the private clinic
                                    <break/>Baji charges PKR 200 for injections</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Codes:
                                    <break/>I am afraid of injections
                                    <break/>The needle is painful
                                    <break/>I cannot prick the injection
                                    <break/>It seems costly
                                    <break/>We cannot afford the cost
                                    <break/>It is difficult for me to self-inject
                                    <break/>I can do it if you train me
                                    <break/>It is like the insulin method for diabetes
                                    <break/>Injection always creates fear
                                    <break/>Inaccurate injection creates problems
                                    <break/>The doctor will be angry if I inject it wrongly
                                    <break/>Cost is high, but it can save time and transportation cost
                                    <break/>We can pay around PKR 50
                                    <break/>It is affordable between PRK 200 to 300
                                    <break/>It will save doctor fees
                                    <break/>Private practitioners will be against this method
                                    <break/>This will reduce the business of Baji (LHV)
                                    <break/>The doctor will not accept it
                                    <break/>Government doctors promote this method
                                    <break/>The community already accepts the injection method
                                    <break/>No reaction in the society
                                    <break/>The government provides this method for free
                                    <break/>It would be good if lady health workers would inject this
                                    <break/>It is easy once we learn the self-injection
                                    <break/>How will doctors accept this because it reduces their
                                    <break/>income</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
            </sec>
            <sec>
                <title>Stage 4: Reviewing themes</title>
                <p>After gathering the codes in two broader areas, those with closer associations were grouped to develop subthemes aligned with the research objectives. This review process was performed considering specific vital questions, as discussed by Maguire and Delahunt
                    <sup>
                        <xref ref-type="bibr" rid="ref-16">16</xref>
                    </sup>.</p>
                <list list-type="bullet">
                    <list-item>
                        <p>Do the themes make sense?</p>
                    </list-item>
                    <list-item>
                        <p>Do the data support the themes?</p>
                    </list-item>
                    <list-item>
                        <p>Am I trying to fit too much into a theme?</p>
                    </list-item>
                    <list-item>
                        <p>If the themes overlap, are they actually separate themes?</p>
                    </list-item>
                    <list-item>
                        <p>Are there themes within themes (subthemes)?</p>
                    </list-item>
                    <list-item>
                        <p>Are there other themes within the data?</p>
                    </list-item>
                </list>
                <p>The details of the reviewed themes and subthemes were summarized following the codes, their meaning, and close associations, avoiding overlapping and considering the research objectives, as provided in 
                    <xref ref-type="table" rid="T2">Table 2</xref>.</p>
                <table-wrap id="T2" orientation="portrait" position="anchor">
                    <label>Table 2. </label>
                    <caption>
                        <title>Details of the subthemes developed with the nearest codes.</title>
                        <p>FP, family planning; DMPA, depot medroxyprogesterone acetate; IM, intramuscular injection; SC, subcutaneous.</p>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Concerns of FP service clients, especially regarding DMPA-IM</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Motives for new product DMPA-SC</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Sub themes:
                                    <break/>Access to FP services</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Sub themes:
                                    <break/>Fear regarding self-administering DMPA-SC</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Affordability for clients of FP services</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Pricing for DMPA-SC</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Barriers to FP Services/DMPA-IM</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Acceptance of DMPA-SC</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">Advantages and disadvantages of injection (DMPA-IM) services</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Affordability/readiness to pay for DMPA-SC</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
            </sec>
            <sec>
                <title>Stage 5: Defining themes</title>
                <p>This stage required the final refinement of the themes by identifying the essence of each theme. It primarily addressed the following questions:</p>
                <list list-type="bullet">
                    <list-item>
                        <p>What theme is presented?</p>
                    </list-item>
                    <list-item>
                        <p>If subthemes exist, do these interact and narrate according to the central theme?</p>
                    </list-item>
                    <list-item>
                        <p>Do the themes correlate with each other?</p>
                    </list-item>
                </list>
                <p>These questions were examined and applied accordingly.</p>
            </sec>
            <sec>
                <title>Stage 6: Write up</title>
                <p>The final stage involved writing the study results, including its findings, conclusions, and recommendations. Next, the data were analyzed using 
                    <ext-link ext-link-type="uri" xlink:href="http://www.qsrinternational.com/nvivo-product">NVivo software</ext-link> version 11 (RRID:SCR_014802) (free alternative, Taguette), as this has been used for similar research objectives that necessitated deductive and inductive codes, requiring deeper involvement in the analysis process. In addition, this method was utilized because it allowed an in-depth understanding of the data and the issue under investigation, which is paramount in qualitative research
                    <sup>
                        <xref ref-type="bibr" rid="ref-17">17</xref>
                    </sup>. Finally, the results were recorded and presented accordingly.</p>
            </sec>
        </sec>
        <sec sec-type="results | discussion">
            <title>Results and Discussion</title>
            <p>The participants were recruited from diverse demographic backgrounds to meet this study&#x2019;s research objectives. After receiving approval from the ethical committee, the participants were recruited with help from local field workers. 
                <xref ref-type="table" rid="T3">Table 3</xref>
                <sup>
                    <xref ref-type="bibr" rid="ref-18">18</xref>
                </sup> presents the demographic profile analysis.</p>
            <table-wrap id="T3" orientation="portrait" position="anchor">
                <label>Table 3. </label>
                <caption>
                    <title>Demographic details of the participants.</title>
                </caption>
                <table content-type="article-table" frame="hsides">
                    <tbody>
                        <tr>
                            <td align="left" colspan="1" rowspan="2" valign="top">
                                <bold>Profession</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>Job</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>Housewife</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>Domestic laborer</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>Agriculture Labor</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>Total</bold>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">8</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">14</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">6</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">5</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">33</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="2" valign="top">
                                <bold>Age Range, Years</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>18&#x2013;30</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>31&#x2013;40</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>41&#x2013;50</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>51 and above</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold/>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">7</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">16</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">8</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">2</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">33</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="2" valign="top">
                                <bold>Education</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>None</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>Primary</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>Middle</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>Matriculation and Higher</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold/>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">16</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">5</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">5</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">7</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">33</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="2" valign="top">
                                <bold>Marital Status</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>Not Married</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>Married</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>Separated</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>Widowed</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold/>
                            </td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">0</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">30</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">1</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">2</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">33</td>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="2" valign="top">
                                <bold>Number of Children</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>0&#x2013;1</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>2&#x2013;3</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>4&#x2013;5</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top">
                                <bold>6 and above</bold>
                            </td>
                            <td align="left" colspan="1" rowspan="1" valign="top"/>
                        </tr>
                        <tr>
                            <td align="left" colspan="1" rowspan="1" valign="top">4</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">8</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">11</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">10</td>
                            <td align="left" colspan="1" rowspan="1" valign="top">33</td>
                        </tr>
                    </tbody>
                </table>
            </table-wrap>
            <p>This study involved the new method of injection DMPA-SC (Sayana Press) for FP, regarding which there is only limited literature. Hence, a deductive coding method was primarily used in the study. Typically, the codes in deductive coding are theoretical concepts or themes drawn from the existing literature, while inductive codes are framed through the analytical process. In a deductive coding approach, the number of codes is typically relatively limited, with approximately five to 10 codes derived from the theoretical framework
                <sup>
                    <xref ref-type="bibr" rid="ref-19">19</xref>
                </sup>. This study&#x2019;s codes were identified following the research objectives. Two major themes were developed, including perceptions of using the existing method of DMPA-IM injection and DMPA-SC Sayana Press. The findings regarding these codes are discussed below.</p>
        </sec>
        <sec>
            <title>Clients&#x2019; perspectives on FP services, especially DMPA-IM</title>
            <sec>
                <title>FP service access</title>
                <p>Participants from the rural areas shared their dependency on public sector services, while 50% of the urban participants preferred selective private healthcare services. Accessibility and shortage of supplies were reported as challenges to accessing the injection method. According to a participant:</p>
                <p>&#x201c;
                    <italic toggle="yes">Civil hospital [government facility] is far from us. We face problems in reaching there, and sometimes when we go there, they have problems with availability and say injections are not available in stock</italic>.&#x201d; (FGD-Hyd; Participant C).</p>
                <p>Clients without financial support depend on the public sector for FP services because they lack options due to resource constraints. According to a participant:</p>
                <p>
                    <italic toggle="yes">&#x201c;Those who had wakfa [Gap / FP services] are likely to be more satisfied with the services of private hospitals, but those who are poor like me remain satisfied with the government hospital because they have no other choice.&#x201d;</italic> (FGD-Suk; Participant B).</p>
                <p>Additionally, in rural areas, women primarily make decisions regarding FP services. Sometimes, they obtain their husband&#x2019;s consent. In other cases, they decide without informing their partner. Furthermore, men are influenced by religious thoughts, as a participant shared:</p>
                <p>
                    <italic toggle="yes">&#x201c;My husband says Allah [God] promised to give us food by hook or crook, then why do you want to have wakfa [FP services]? Now my husband does not know I had wakfa. But he is saying we will give birth to a little baby girl because all other children are young, and now we should have a little baby.&#x201d;</italic> (FGD-Suk; Participant G)</p>
                <p>These results align with previous research findings, suggesting that the family size is larger among families where the husband opposes contraceptives because of a perceived religious prohibition of their use
                    <sup>
                        <xref ref-type="bibr" rid="ref-20">20</xref>
                    </sup>.</p>
            </sec>
            <sec>
                <title>Affordability of FP services for clients</title>
                <p>Poverty was a complex challenge across all the FGDs. It was worse in rural areas, as a participant shared:</p>
                <p>
                    <italic toggle="yes">&#x201c;Sometimes our children do not have a copy [notebook for writing] or pen, or sometimes they do not have a dress. So, we put more effort into making handicrafts and selling them. We fulfill our needs and hope for a brighter future for our children; it is not possible to spend money on FP services.&#x201d;</italic> (FGD-Suk; Participant B)</p>
                <p>Clients in rural and urban areas receive injectable contraceptives free of charge at public sector facilities and pay charges only for transportation. By contrast, while at private facilities, they must pay for both service charges and transportation costs. However, certain factors motivate clients who can afford to visit private health facilities. Regarding the comparison of public and private hospital services in terms of their availability, a participant shared:</p>
                <p>
                    <italic toggle="yes">&#x201c;People with no financial issues go to private clinics to save time and believe that things that are free of cost are not reliable. I have experienced both private and public facilities, and I can surely say that government commodities are reliable, and their services are better than private facilities.&#x201d;</italic> (FGD-Kar; Participant D)</p>
                <p>It was found that even in the presence of substantial information regarding family planning methods in the community, it is still difficult to get agreement from female clients to start contraception. This perspective aligned with a previous study&#x2019;s findings that women find accepting the FP method and its cost challenging
                    <sup>
                        <xref ref-type="bibr" rid="ref-21">21</xref>
                    </sup>. According to a participant:</p>
                <p>
                    <italic toggle="yes">&#x201c;Convincing women for FP is difficult; if it is hard to convince people to receive the free-of-charge FP method, it would be much harder to convince them to pay from their domestic earnings for FP.&#x201d;</italic> (FGD-Kar; Participant E)</p>
                <p>We also found that given the lack of options for FP, clients from all settings were willing to pay PKR 50&#x2013;300 to only private providers as service charges for injectable contraceptives.</p>
            </sec>
            <sec>
                <title>Barriers to FP services (DMPA-IM)</title>
                <p>Women&#x2019;s ability to travel is a significant barrier to accessing FP services, including DMPA-IM injection. According to a participant:</p>
                <p>
                    <italic toggle="yes">&#x201c;Transportation and affordability are big issues. Do you know why? Suppose a woman has six children; take my example, I have six children, and my husband does not have any proper income. So, I can hardly pay the bus fare. If I request another woman to accompany me, I would have to pay her fare, too, because I am taking her for my FP, which is free of cost, but I cannot afford both expenses. If the government provides me with transportation facility, I could feel at ease that I received a method that is free of cost and my transportation is also free.&#x201d;</italic> (FGD-Kar; Participant D)</p>
                <p>These findings align with the results shared by male participants in a study conducted by Dr. Sara Saleem and colleagues in Pakistan
                    <sup>
                        <xref ref-type="bibr" rid="ref-21">21</xref>
                    </sup>. Deciding on FP and the unavailability of counseling services were also reported as barriers in the study. According to a participant:</p>
                <p>
                    <italic toggle="yes">&#x201c;Last December, I gave birth to a baby girl, and she suddenly died after birth because I had not planned my pregnancy or delivery. I mean to say that we women often take risks to have another child but do not come forward for the FP method. It is very difficult for us to decide about opting for FP methods. But the services of FP workers are very good, as they mobilize people to come forward, take a decision, and get FP method.&#x201d;</italic> (FGD-Kar; Participant E)</p>
                <p>Notably, women appreciated the role of health workers in mobilizing clients and helping them decide whether to access FP services.</p>
            </sec>
            <sec>
                <title>Advantages and disadvantages of injection (DMPA-IM) services</title>
                <p>Most participants shared that injectables can readily be accessed, while some reported that a shortage of supplies and perceived side effects are significant disadvantages. The injection method was preferred among participants. A few of the crucial benefits, according to the participants, included the following:</p>
                <p>
                    <italic toggle="yes">&#x201c;Injection means three months of relaxation.&#x201d;</italic> (FGD-Kar; Participant E).</p>
                <p>
                    <italic toggle="yes">&#x201c;As I have observed, the injection is effective because I had also used pills, but it caused menstrual cycle two or three times in a month.&#x201d;</italic> (FGD-Hyd; Participant A)</p>
                <p>The leading client perception regarding existing DMPA-IM included changes in the menstrual cycle as disadvantages of injection, aligning with previous studies
                    <sup>
                        <xref ref-type="bibr" rid="ref-21">21</xref>
                    </sup>. According to participants:</p>
                <p>
                    <italic toggle="yes">&#x201c;There is a problem; I heard that the injections available in the government hospitals are not of good quality and are less effective. My aunt shared with me about her health and weakness, similar to what I felt, especially blood pressure problems, after using the injection method.&#x201d;</italic> (FGD-Hyd; Participant C)</p>
                <p>
                    <italic toggle="yes">&#x201c;Women do not get periods after taking an injection. In a month, we are fine for 10 days, but after 20 days, we start feeling ill.&#x201d;</italic> (FGD-Suk; Participant G).</p>
            </sec>
        </sec>
        <sec>
            <title>Perspectives of the new product (DMPA-SC)</title>
            <sec>
                <title>Fear regarding self-administration of DMPA-SC</title>
                <p>We found that participants in all settings showed moderate fear of self-injection. Information regarding the new method is minimal. Moreover, even those aware may not know about its self-injection features. After presenting a demonstration of the new method and observing Sayana Press physically, participants shared their concerns regarding self-injection, specifically the risk of an inaccurate prick, aligning with other studies conducted worldwide that revealed such fear associated with self-injection
                    <sup>
                        <xref ref-type="bibr" rid="ref-11">11</xref>,
                        <xref ref-type="bibr" rid="ref-21">21</xref>
                    </sup>. Participants lacked information about the new method and its self-injection features. However, they showed a willingness to use the self-injection method after adequate training. According to participants:</p>
                <p>
                    <italic toggle="yes">&#x201c;If I cannot inject others, then how can I do it for myself, and if I prick it wrong, what would I do? However, I can do it if someone trained me.&#x201d;</italic> (FGD-Suk; Participant B).</p>
                <p>
                    <italic toggle="yes">&#x201c;It will be beneficial for us since we are busy with in-house chores; if I forget the injection date, I start feeling fearful, and another point is that if we get an injection by a doctor, we feel ill or unhealthy. If we receive an injection for self-use, we will feel good. However, about the concern of self-administration, after a few times, it will be easy to perform, and finally, the fear will be over.&#x201d;</italic> (FGD-Kar; Participant D).</p>
            </sec>
            <sec>
                <title>Pricing for DMPA-SC</title>
                <p>Most participants appreciated the free services at the public sector health facilities. However, economically compromised clients have difficulty paying private providers to access the injection at a private facility. In addition, we found that the affordability of DMPA-SC is challenging in the private sector, especially for low-income clients. Participants also assumed that DMPA-SC must be expensive. According to participants:</p>
                <p>
                    <italic toggle="yes">&#x201c;I think this must have a high price because this is a new method and has different features.&#x201d;</italic> (FGD-Kar; Participant K)</p>
                <p>&#x201c;
                    <italic toggle="yes">Poor people cannot afford costly injections, and this seems costly.</italic>&#x201d; (FGD-Suk; Participant G)</p>
                <p>
                    <italic toggle="yes">&#x201c;I think if it is expensive, by hook or crook, we can manage to pay, but if there is a reaction, we may die or face complications.</italic>&#x201d; (FGD-Hyd; Participant C)</p>
                <p>This viewpoint is similar to the perceptions of Nigerian clients; the perceived cost to clients was among the most significant concerns
                    <sup>
                        <xref ref-type="bibr" rid="ref-23">23</xref>
                    </sup>. Participants in this study agreed to pay between PKR 50 and 300 (equivalent to 1 USD) as service charges to private providers. Others agreed to pay transportation costs to receive free public sector health facility services.</p>
            </sec>
            <sec>
                <title>Acceptance of DMPA-SC</title>
                <p>Clients preferred the self-injection method to avoid private providers&#x2019; transportation and service charges after adequate training. According to a participant:</p>
                <p>&#x201c;
                    <italic toggle="yes">To avoid transportation issues, especially for those women who go outside for services, home-based service is better.</italic>&#x201d; (FGD-Kar; Participant C)</p>
                <p>This opinion aligns with findings from a study in Ghana, where women preferred a home-based self-injection method to avoid transportation costs, waiting time at service providers, privacy, and unavailability of providers during their visit
                    <sup>
                        <xref ref-type="bibr" rid="ref-24">24</xref>
                    </sup>. In addition, most participants shared that accepting DMPA-SC is not concerning, especially at the community level. However, acceptance and threats from private providers were found in the current study. According to participants:</p>
                <p>
                    <italic toggle="yes">&#x201c;Self-injection will decrease the number of clients coming for injection, so private service providers will spread misinformation about this new method; for example, they can strengthen the perception of inaccurate prick and its negative consequences.&#x201d;</italic> (FDG-Kar; Participant I)</p>
                <p>
                    <italic toggle="yes">&#x201c;Private doctors are charging a 50 rupees fee for injection and wish that more patients would come, so their business will go down with the self-injection method</italic>. 
                    <italic toggle="yes">However, the government doctor wishes that patients would not come to them and consider them a headache.&#x201d;</italic> (FGD-Hyd; Participant B)</p>
                <p>
                    <italic toggle="yes">&#x201c;The doctor would be angry about this if something went wrong. The best option is to get an injection from the doctor.&#x201d;</italic> (FGD-Suk; Participant G)</p>
                <p>The present study confirms the perceived likelihood of threat from the service providers for self-injections, aligning with the findings of Spieler
                    <sup>
                        <xref ref-type="bibr" rid="ref-5">5</xref>
                    </sup>, who suggested that doctors, nurses, ministries of health, and midwives may feel threatened (because, historically, a medical doctor administers injections) and create a backlash against using a product that is self-injected
                    <sup>
                        <xref ref-type="bibr" rid="ref-5">5</xref>
                    </sup>.</p>
            </sec>
            <sec>
                <title>Affordability and readiness to pay for DMPA-SC</title>
                <p>Most participants agreed to pay private providers PKR 50&#x2013;300 (approximately 1 USD) as service charges. By contrast, others agreed to pay for the transportation cost if they did not have options for other methods. According to participants:</p>
                <p>
                    <italic toggle="yes">&#x201c;The maximum that I can afford is 200 to 300 (PKR), but I will have an agreement with that doctor on stamp beforehand that if I become ill, then they will bear all expenses of my treatment, and it would be their responsibility.&#x201d;</italic> (FGD-Suk; Participant G)</p>
                <p>
                    <italic toggle="yes">&#x201c;Maximum of 200 to 250</italic> (PKR)
                    <italic toggle="yes">; if it is more than this amount, up to 1,000 rupees, no one can buy or afford.&#x201d;</italic> (FGD-Suk; Participant B)</p>
                <p>
                    <italic toggle="yes">&#x201c;Normally an injection costs 150 to 200 rupees at a private clinic, so if it is safe, women can afford it.&#x201d;</italic> (FGD-Kar; Participant K)</p>
                <p>
                    <italic toggle="yes">&#x201c;If it is in our budget to get wakfa, we will purchase it; that is a maximum of 50 to 100 rupees.&#x201d;</italic> (FGD-Hyd; Participant A)</p>
                <p>This outcome is consistent with the findings of a previous study that the clients&#x2019; estimate of affordable pricing for three months of contraceptive injections in India and Nigeria ranges from 1.25 to 2.89 USD
                    <sup>
                        <xref ref-type="bibr" rid="ref-25">25</xref>
                    </sup>, matching the approximate price reported in this study (approximately 1 to 1.5 USD).</p>
                <p>The clients preferred Sayana Press over DMPA-IM when choosing between injectable methods
                    <sup>
                        <xref ref-type="bibr" rid="ref-26">26</xref>
                    </sup>. The clients&#x2019; reported acceptability and satisfaction regarding Sayana Press was substantial
                    <sup>
                        <xref ref-type="bibr" rid="ref-27">27</xref>
                    </sup>, especially during its second dose in their homes, when this trend increased significantly
                    <sup>
                        <xref ref-type="bibr" rid="ref-24">24</xref>
                    </sup>. The current study confirms the lack of adequate information about its side effects and overall understanding of self-injection
                    <sup>
                        <xref ref-type="bibr" rid="ref-4">4</xref>,
                        <xref ref-type="bibr" rid="ref-28">28</xref>
                    </sup>. According to a participant:</p>
                <p>
                    <italic toggle="yes">&#x201c;After having the FP injection (DMPA-IM), I had cardio issues and felt continuous pain on the side on which the injection was received.&#x201d;</italic>
                </p>
                <p>This study thus demonstrates the need for accurate information and counseling regarding FP methods and side effects for the successful implementation of DMPA-SC. In addition, in some countries, increased knowledge of self-injection is high; however, the uptake is low
                    <sup>
                        <xref ref-type="bibr" rid="ref-28">28</xref>
                    </sup>. Hence, service access must be increased by engaging service providers, medical students, and community workers to improve the utility of Sayana Press, especially by promoting self-injection.</p>
            </sec>
        </sec>
        <sec sec-type="conclusions">
            <title>Conclusions</title>
            <p>DMPA-SC can be a valuable asset and have a catalytic effect on the uptake of FP services, given adequate counseling. After training, the clients were willing to use this self-injection approach with the providers&#x2019; assistance. Additionally, they agreed to pay the transportation cost to obtain the contraceptive for free at public sector health facilities or without any transportation within communities through health workers. Clients preferred the self-injection method after training to avoid transportation and private provider service charges. Future studies must be conducted with clients who avail themselves of the services of DMAP-SC from service providers and use the self-injection method.</p>
        </sec>
        <sec>
            <title>Practical implications</title>
            <p>The Government of Sindh under CIP conducted a randomized controlled trial to provide the injectable contraceptives DMPA-IM and DMPA-SC (Sayana Press) through lady health workers in 2018&#x2013;19, with support from Family Health International (FHI360), Aga Khan University (AKU), and Jhpiego
                <sup>
                    <xref ref-type="bibr" rid="ref-4">4</xref>
                </sup>. Registration of DMPA-SC was approved by the Drug Regulatory Authority of Pakistan in December 2018. A rollout and scale-up plan (2019&#x2013;2023) for Sayana Press in Sindh was developed with support from RIZ Consulting, emphasizing self-injection. This study&#x2019;s findings can help the Government of Sindh and other stakeholders with decision-making and implementing DMPA-SC provider assistance and self-injection as they apply the scale-up plan. In particular, the present study will help policymakers address challenges regarding the fear of pain and inaccurate pricking during self-injection. Further, the information related to the affordability of new contraceptive methods will assist the government and private sector in keeping the price within clients&#x2019; budgets.</p>
        </sec>
    </body>
    <back>
        <sec sec-type="data-availability">
            <title>Data availability</title>
            <sec>
                <title>Underlying data</title>
                <p>The compiled transcripts of the focus group discussions have been published and are accessible at Mendeley Data, while the raw transcripts cannot be shared publicly because of potentially sensitive participant information following the decision of the ethics committee of the Institute of Business Management (IoBM), Karachi. Data are available to researchers who meet the criteria for access to confidential data by contacting Ghulam Yaseen Veesar (
                    <email xlink:href="mailto:yaseenveesar@yahoo.com">yaseenveesar@yahoo.com</email>), a PhD scholar at IoBM, Karachi.</p>
                <p>Mendeley Data: Dataset for Transpire the benefits, fears, acceptance and barriers to the new injectable contraceptive DMPA-SC (Sayana Press)- Perception of clients in Sindh, Pakistan. 
                    <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17632/dcdn2222xx.1">https://doi.org/10.17632/dcdn2222xx.1</ext-link>
                    <sup>
                        <xref ref-type="bibr" rid="ref-18">18</xref>
                    </sup>.</p>
                <p>Data are available under the terms of the 
                    <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/legalcode">Creative Commons Attribution 4.0 International license</ext-link> (CC-BY 4.0).</p>
            </sec>
        </sec>
        <ack>
            <title>Acknowledgments</title>
            <p>The authors are very grateful to all the research participants for their voluntary support. We are also thankful to the Research Ethics Review Committee, Health and Hospital Management Program, Institute of Business Management, Karachi, for their ethical approval of the study.</p>
        </ack>
        <ref-list>
            <ref id="ref-1">
                <label>1</label>
                <mixed-citation publication-type="journal">
                    <collab>P. B. O. Statistics</collab>:
                    <article-title>Census Report.</article-title>Government of Pakistan, Islamabad, Pakistan,<year>2019</year>.
                    <ext-link ext-link-type="uri" xlink:href="https://www.pbs.gov.pk/content/population-census">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-2">
                <label>2</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Corsa</surname>
                            <given-names>L</given-names>
                            <suffix>Jr</suffix>
                        </name>
</person-group>:
                    <article-title>Family planning in Pakistan.</article-title>
                    <source>

                        <italic toggle="yes">Am J Public Health.</italic>
</source>
                    <year>1965</year>;<volume>55</volume>(<issue>3</issue>):<fpage>400</fpage>&#x2013;<lpage>403</lpage>.
                    <pub-id pub-id-type="doi">10.2105/ajph.55.3.400</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-3">
                <label>3</label>
                <mixed-citation publication-type="journal">
                    <collab>P. B. O. Statistics</collab>:
                    <article-title>Pakistan Health and Demographic Survey.</article-title>Government of Pakistan, Pakistan,<year>2019</year>.
                    <ext-link ext-link-type="uri" xlink:href="https://www.rhsupplies.org/activities-resources/publications/pakistan-demographic-and-health-survey-2019-8199/">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-4">
                <label>4</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Chin-Quee</surname>
                            <given-names>DS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Abrejo</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Chen</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Task sharing of injectable contraception services in Pakistan: A randomized controlled trial.</article-title>
                    <source>

                        <italic toggle="yes">Stud Fam Plann.</italic>
</source>
                    <year>2021</year>;<volume>52</volume>(<issue>1</issue>):<fpage>23</fpage>&#x2013;<lpage>39</lpage>.
                    <pub-id pub-id-type="pmid">33742478</pub-id>
                    <pub-id pub-id-type="doi">10.1111/sifp.12149</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-5">
                <label>5</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Spieler</surname>
                            <given-names>J</given-names>
                        </name>
</person-group>:
                    <article-title>Sayana&#x00ae; Press: Can it be a &#x201c;game changer&#x201d; for reducing unmet need for family planning?</article-title>
                    <source>

                        <italic toggle="yes">Contraception.</italic>
</source>
                    <year>2014</year>;<volume>89</volume>(<issue>5</issue>):<fpage>335</fpage>&#x2013;<lpage>8</lpage>.
                    <pub-id pub-id-type="pmid">24703826</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.contraception.2014.02.010</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-6">
                <label>6</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Patel</surname>
                            <given-names>S</given-names>
                        </name>
</person-group>:
                    <article-title>Manufacturer&#x2019;s response to letter about &#x2018;Sayana Press and a case of likely lipoatrophy&#x2019;.</article-title>
                    <source>

                        <italic toggle="yes">BMJ Sex Reprod Health.</italic>
</source>
                    <year>2018</year>;<volume>44</volume>(<issue>4</issue>):<fpage>314</fpage>.
                    <pub-id pub-id-type="pmid">30305410</pub-id>
                    <pub-id pub-id-type="doi">10.1136/bmjsrh-2018-200201</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-7">
                <label>7</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Pfizer</surname>
                        </name>
</person-group>:
                    <article-title>SAYANA PRESS 104 mg/0.65 ml Suspension for Injection.</article-title>15
                    <sup>th</sup>
                    <year> 2022</year>.
                    <ext-link ext-link-type="uri" xlink:href="https://www.medicines.org.uk/emc/product/3148/smpc#gref">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-8">
                <label>8</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Sindh</surname>
                            <given-names>GO</given-names>
                        </name>
</person-group>:
                    <article-title>Costed Implementation Plan (CIP) on Family Planning for Sindh.</article-title>Government of Sindh, Karachi,<year>2015</year>.
                    <ext-link ext-link-type="uri" xlink:href="https://fpfinancingroadmap.org/resources/costed-implementation-plan-cip-family-planning-sindh-2015-2020">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-9">
                <label>9</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Quee</surname>
                            <given-names>DC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Olsen</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Chen</surname>
                            <given-names>M</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Provision of injectable contraception by lady health workers and lady health visitors: A randomized controlled trial in Pakistan.</article-title>
                    <source>

                        <italic toggle="yes">FHI360.</italic>
</source>
                    <year>2019</year>.</mixed-citation>
            </ref>
            <ref id="ref-10">
                <label>10</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Plan</surname>
                            <given-names>CI</given-names>
                        </name>
</person-group>:
                    <article-title>Key Learnings from Pilot on DMPA-SC Self Injection.</article-title>Government of Sindh, Karachi,<year>2022</year>.</mixed-citation>
            </ref>
            <ref id="ref-11">
                <label>11</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Nyumba</surname>
                            <given-names>TO</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Wilson</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Derrick</surname>
                            <given-names>CJ</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The use of focus group discussion methodology: Insights from two decades of application in conservation.</article-title>
                    <source>

                        <italic toggle="yes">Methods Ecol Evol.</italic>
</source>
                    <year>2018</year>;<volume>9</volume>(<issue>1</issue>):<fpage>20</fpage>&#x2013;<lpage>32</lpage>.
                    <pub-id pub-id-type="doi">10.1111/2041-210X.12860</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-12">
                <label>12</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>van Eeuwijk</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Angehrn</surname>
                            <given-names>Z</given-names>
                        </name>
</person-group>:
                    <article-title>How to &#x2026; Conduct a Focus Group Discussion (FGD).</article-title>Methodological Manual. University of Basel, Basel,<year>2017</year>.
                    <pub-id pub-id-type="doi">10.5167/uzh-150640</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-13">
                <label>13</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Guest</surname>
                            <given-names>G</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Namey</surname>
                            <given-names>E</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mckenna</surname>
                            <given-names>K</given-names>
                        </name>
</person-group>:
                    <article-title>How many focus groups are enough? Building an evidence base for nonprobability sample sizes.</article-title>
                    <source>

                        <italic toggle="yes">Field Methods.</italic>
</source>
                    <year>2017</year>;<volume>29</volume>(<issue>1</issue>):<fpage>3</fpage>&#x2013;<lpage>22</lpage>.
                    <pub-id pub-id-type="doi">10.1177/1525822X16639015</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-14">
                <label>14</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>DeVon</surname>
                            <given-names>HA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Block</surname>
                            <given-names>ME</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Moyle-Wright</surname>
                            <given-names>P</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>A psychometric toolbox for testing validity and reliability.</article-title>
                    <source>

                        <italic toggle="yes">J Nurs Scholarsh.</italic>
</source>
                    <year>2007</year>;<volume>39</volume>(<issue>2</issue>):<fpage>155</fpage>&#x2013;<lpage>64</lpage>.
                    <pub-id pub-id-type="pmid">17535316</pub-id>
                    <pub-id pub-id-type="doi">10.1111/j.1547-5069.2007.00161.x</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-15">
                <label>15</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Braun</surname>
                            <given-names>V</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Clarke</surname>
                            <given-names>V</given-names>
                        </name>
</person-group>:
                    <article-title>Using thematic analysis in psychology.</article-title>
                    <source>

                        <italic toggle="yes">Qual Res Psychol.</italic>
</source>
                    <year>2006</year>;<volume>3</volume>(<issue>2</issue>):<fpage>77</fpage>&#x2013;<lpage>101</lpage>.
                    <pub-id pub-id-type="doi">10.1191/1478088706qp063oa</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-16">
                <label>16</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Maguire</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Delahunt</surname>
                            <given-names>B</given-names>
                        </name>
</person-group>:
                    <article-title>Doing a thematic analysis: A practical, step-by-step guide for learning and teaching scholars.</article-title>
                    <source>

                        <italic toggle="yes">All Ireland Journal of Higher Education.</italic>
</source>
                    <year>2017</year>;<volume>9</volume>(<issue>3</issue>):<fpage>3351</fpage>&#x2013;<lpage>33514</lpage>.
                    <ext-link ext-link-type="uri" xlink:href="https://ojs.aishe.org/index.php/aishe-j/article/view/335">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-17">
                <label>17</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Sotiriadou</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Brouwers</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Le</surname>
                            <given-names>TA</given-names>
                        </name>
</person-group>:
                    <article-title>Choosing a qualitative data analysis tool: A comparison of NVivo and Leximancer.</article-title>
                    <source>

                        <italic toggle="yes">Ann Leis Res.</italic>
</source>
                    <year>2014</year>;<volume>17</volume>(<issue>2</issue>):<fpage>218</fpage>&#x2013;<lpage>234</lpage>.
                    <pub-id pub-id-type="doi">10.1080/11745398.2014.902292</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-18">
                <label>18</label>
                <mixed-citation publication-type="data">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Veesar</surname>
                            <given-names>GY</given-names>
                        </name>
</person-group>:
                    <data-title>Dataset for Transpire the benefits, fears, acceptance and barriers to the new injectable contraceptive DMPA-SC (Sayana Press)- Perception of clients in Sindh, Pakistan.</data-title>
                    <source>

                        <italic toggle="yes">Mendeley Data, V1.</italic>
</source>[Dataset],<year>2022</year>.
                    <ext-link ext-link-type="uri" xlink:href="http://www.doi.org/10.17632/dcdn2222xx.1">http://www.doi.org/10.17632/dcdn2222xx.1</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref-19">
                <label>19</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Linneberg</surname>
                            <given-names>MS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Korsgaard</surname>
                            <given-names>S</given-names>
                        </name>
</person-group>:
                    <article-title>Coding qualitative data: A synthesis guiding the novice.</article-title>
                    <source>

                        <italic toggle="yes">Qual Res J.</italic>
</source>
                    <year>2019</year>;<volume>19</volume>(<issue>3</issue>):<fpage>259</fpage>&#x2013;<lpage>270</lpage>.
                    <pub-id pub-id-type="doi">10.1108/QRJ-12-2018-0012</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-20">
                <label>20</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Asif</surname>
                            <given-names>MF</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pervaiz</surname>
                            <given-names>Z</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Afridi</surname>
                            <given-names>JR</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Role of husband&#x2019;s attitude towards the usage of contraceptives for unmet need of family planning among married women of reproductive age in Pakistan.</article-title>
                    <source>

                        <italic toggle="yes">BMC Women's Health.</italic>
</source>
                    <year>2021</year>;<volume>21</volume>(<issue>1</issue>):<fpage>163</fpage>.
                    <pub-id pub-id-type="pmid">33874926</pub-id>
                    <pub-id pub-id-type="doi">10.1186/s12905-021-01314-4</pub-id>
                    <pub-id pub-id-type="pmcid">8056490</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-21">
                <label>21</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Saleem</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Rizvi</surname>
                            <given-names>N</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Feroze</surname>
                            <given-names>AS</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Perceptions and experiences of men and women towards acceptability and use of contraceptives in underserved areas of Karachi, Pakistan: A midline qualitative assessment of Sukh initiative, Karachi Pakistan.</article-title>
                    <source>

                        <italic toggle="yes">Reprod Health.</italic>
</source>
                    <year>2020</year>;<volume>17</volume>(<issue>1</issue>):<fpage>95</fpage>.
                    <pub-id pub-id-type="pmid">32546169</pub-id>
                    <pub-id pub-id-type="doi">10.1186/s12978-020-00946-3</pub-id>
                    <pub-id pub-id-type="pmcid">7298815</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-22">
                <label>22</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Keith</surname>
                            <given-names>B</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Wood</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Chapman</surname>
                            <given-names>C</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Perceptions of home and self-injection of Sayana&#x00ae; Press in Ethiopia: A qualitative study.</article-title>
                    <source>

                        <italic toggle="yes">Contraception.</italic>
</source>
                    <year>2014</year>;<volume>89</volume>(<issue>5</issue>):<fpage>379</fpage>&#x2013;<lpage>384</lpage>.
                    <pub-id pub-id-type="pmid">24529492</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.contraception.2013.12.010</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-23">
                <label>23</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Eremutha</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Gabriel</surname>
                            <given-names>V</given-names>
                        </name>
</person-group>:
                    <article-title>Awareness, knowledge, and perception about Sayana press&#x00ae; contraceptive technology in Nigeria.</article-title>
                    <source>

                        <italic toggle="yes">Trop J Obstet Gynaecol.</italic>
</source>
                    <year>2019</year>;<volume>36</volume>(<issue>3</issue>):<fpage>459</fpage>&#x2013;<lpage>464</lpage>.
                    <pub-id pub-id-type="doi">10.4103/TJOG.TJOG_81_19</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-24">
                <label>24</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Nai</surname>
                            <given-names>D</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Aboagye</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Fuseini</surname>
                            <given-names>K</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Introduction of DMPA-SC Self-injection in Ghana: A Feasibility and Acceptability Study Using Sayana&#x00ae; Press.</article-title>Population Council, The Evidence Project, Washington, DC,<year>2020</year>.
                    <pub-id pub-id-type="doi">10.31899/rh11.1050</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-25">
                <label>25</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Brunie</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Callahan</surname>
                            <given-names>RL</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Godwin</surname>
                            <given-names>CL</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>User preferences for a contraceptive microarray patch in India and Nigeria: Qualitative research on what women want.</article-title>
                    <source>

                        <italic toggle="yes">PLoS One.</italic>
</source>
                    <year>2019</year>;<volume>14</volume>(<issue>6</issue>):<fpage>e0216797</fpage>.
                    <pub-id pub-id-type="pmid">31170173</pub-id>
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0216797</pub-id>
                    <pub-id pub-id-type="pmcid">6553846</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-26">
                <label>26</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Sherpa</surname>
                            <given-names>LY</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Tinkari</surname>
                            <given-names>BS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Gentle</surname>
                            <given-names>P</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>A prospective cohort study to assess the acceptability of Sayana Press among 18-49-year-old women in Nepal.</article-title>
                    <source>

                        <italic toggle="yes">Contraception.</italic>
</source>
                    <year>2021</year>;<volume>104</volume>(<issue>6</issue>):<fpage>623</fpage>&#x2013;<lpage>627</lpage>.
                    <pub-id pub-id-type="pmid">34280441</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.contraception.2021.07.009</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-27">
                <label>27</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Bertrand</surname>
                            <given-names>JT</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Makani</surname>
                            <given-names>PB</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hernandez</surname>
                            <given-names>J</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Acceptability of the community-level provision of Sayana&#x00ae; Press by medical and nursing students in Kinshasa, Democratic Republic of the Congo.</article-title>
                    <source>

                        <italic toggle="yes">Contraception.</italic>
</source>
                    <year>2017</year>;<volume>96</volume>(<issue>3</issue>):<fpage>211</fpage>&#x2013;<lpage>215</lpage>.
                    <pub-id pub-id-type="pmid">28647500</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.contraception.2017.05.014</pub-id>
                    <pub-id pub-id-type="pmcid">5570913</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref-28">
                <label>28</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Idowu</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Osinusi</surname>
                            <given-names>E</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Awubite</surname>
                            <given-names>LE</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Contraceptive self-injection knowledge, attitude and practices among female students of a tertiary health institution in south west Nigeria.</article-title>
                    <source>

                        <italic toggle="yes">Int J Reprod Contracept Obstet Gynecol.</italic>
</source>
                    <year>2022</year>;<volume>11</volume>(<issue>2</issue>):<fpage>323</fpage>&#x2013;<lpage>331</lpage>.
                    <pub-id pub-id-type="doi">10.18203/2320-1770.ijrcog20220155</pub-id>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
    <sub-article article-type="reviewer-report" id="report33809">
        <front-stub>
            <article-id pub-id-type="doi">10.21956/gatesopenres.15637.r33809</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Cover</surname>
                        <given-names>Jane</given-names>
                    </name>
                    <xref ref-type="aff" rid="r33809a1">1</xref>
                    <role>Referee</role>
                </contrib>
                <aff id="r33809a1">
                    <label>1</label>PATH, Seattle, Washington, USA</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>17</day>
                <month>7</month>
                <year>2024</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2024 Cover J</copyright-statement>
                <copyright-year>2024</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport33809" related-article-type="peer-reviewed-article" xlink:href="10.12688/gatesopenres.14326.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>This is an interesting article from a country of great interest with relatively few studies focused on family planning. It is well-written and a good addition to the literature on injectable contraception and self-care in a South Asian context.</p>
            <p> </p>
            <p> The study is clearly presented. It would benefit from a deeper read of the literature. There are some key publications that are relevant and missing. For example, Burke 
                <italic>et al.</italic> (2014)Ref 1 and Polis 
                <italic>et al. </italic>(2014)Ref 2 did the original acceptability studies comparing DMPA-IM and DMPA-SC, and Cover, 
                <italic>et al.</italic> (2017)Ref 3 the early work on self-injection acceptability. In addition to reflecting more depth of understanding of the field, I would recommend double checking the reference list as it looks like reference 11 is not about fear of self-injection. (Though there are quite a number of publications that discuss injection fear, for example, Cover 
                <italic>et al.</italic>, (2022)Ref 4 and Burke 
                <italic>et al.</italic>, 2022)Ref 5.&#x00a0;</p>
            <p> </p>
            <p> I found the first paragraph discussing method use in Pakistan to be confusing.&#x00a0;It is customary to express method use in terms of the percent of women using FP methods (CPR) or specific methods, or the percent of the method mix represented by a given method. (In the first two cases, the denominator is all women and in the latter case, it is women who are using a method). I would propose that, in addition to providing the percent of women using the top 3-4 methods (as you have done), you also provide the method mix (among users, what percent are using each method) to conform to an approach that will be more familiar to readers.</p>
            <p> </p>
            <p> With respect to the methods, I would cut back substantially on the details from the methods recommended by Braun and Clark. This is more than what is needed to describe your approach. In place of that, it would be helpful to learn more about 1) how women were selected (yes, purposively, but what approach was used to recruit them?) and 2) the full selection criteria (was marital status the only criteria? Were they contraceptive users? In a particular age range, etc.?).&#x00a0;</p>
            <p> </p>
            <p> I was interested to see the education range, which is quite broad. It sounds from your methods as though you may have tried to increase diversity (including by education) within each focus group. (Related to this, for table 3, it would be helpful to see the breakdown of characteristics by FGD). Usually, we aim to create more homogeneous FGDs, which maximizes active participation. People are more likely to speak up when they feel they are among their peers. One can imagine that a woman who has not been to school could feel quite inhibited to express her opinion in a group of women with higher education. Similarly, an adolescent will be reluctant to speak up in a group with older women. While I don't think this is a 'fatal flaw', it may be a study limitation that should be mentioned, with your perceptions of what the impact may have been on the tenor of the conversation. In other words, did women with less education (or younger age) fully participate?&#x00a0;&#x00a0;</p>
            <p> </p>
            <p> Generally speaking, this is a worthwhile paper that shares interesting findings. In particular, the discussion of potential active opposition to self-injection among private providers is intriguing. A future study to assess/quantify that possibility may be merited. With some relatively minor edits, this paper will be a nice addition to the literature.</p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>Partly</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>Not applicable</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Yes</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>Yes</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>Yes</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>Partly</p>
            <p>Reviewer Expertise:</p>
            <p>Sexual and reproductive health; contraceptive methods; self-care and self-injection; HIV prevention</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
        <back>
            <ref-list>
                <title>References</title>
                <ref id="rep-ref-33809-1">
                    <label>1</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>Observational study of the acceptability of Sayana&#x00ae; Press among intramuscular DMPA users in Uganda and Senegal.</article-title>
                        <source>
                            <italic>Contraception</italic>
                        </source>.<year>2014</year>;<volume>89</volume>(<issue>5</issue>) :
                        <elocation-id>10.1016/j.contraception.2014.01.022</elocation-id>
                        <fpage>361</fpage>-<lpage>7</lpage>
                        <pub-id pub-id-type="pmid">24631328</pub-id>
                        <pub-id pub-id-type="doi">10.1016/j.contraception.2014.01.022</pub-id>
                    </mixed-citation>
                </ref>
                <ref id="rep-ref-33809-2">
                    <label>2</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>Preference for Sayana&#x00ae; Press versus intramuscular Depo-Provera among HIV-positive women in Rakai, Uganda: a randomized crossover trial.</article-title>
                        <source>
                            <italic>Contraception</italic>
                        </source>.<year>2014</year>;<volume>89</volume>(<issue>5</issue>) :
                        <elocation-id>10.1016/j.contraception.2013.11.008</elocation-id>
                        <fpage>385</fpage>-<lpage>95</lpage>
                        <pub-id pub-id-type="pmid">24332432</pub-id>
                        <pub-id pub-id-type="doi">10.1016/j.contraception.2013.11.008</pub-id>
                    </mixed-citation>
                </ref>
                <ref id="rep-ref-33809-3">
                    <label>3</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>A prospective cohort study of the feasibility and acceptability of depot medroxyprogesterone acetate administered subcutaneously through self-injection.</article-title>
                        <source>
                            <italic>Contraception</italic>
                        </source>.<year>2017</year>;<volume>95</volume>(<issue>3</issue>) :
                        <elocation-id>10.1016/j.contraception.2016.10.007</elocation-id>
                        <fpage>306</fpage>-<lpage>311</lpage>
                        <pub-id pub-id-type="pmid">27789309</pub-id>
                        <pub-id pub-id-type="doi">10.1016/j.contraception.2016.10.007</pub-id>
                    </mixed-citation>
                </ref>
                <ref id="rep-ref-33809-4">
                    <label>4</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>Contraceptive self-injection through routine service delivery: Experiences of Ugandan women in the public health system.</article-title>
                        <source>
                            <italic>Front Glob Womens Health</italic>
                        </source>.<year>2022</year>;<volume>3</volume>:
                        <elocation-id>10.3389/fgwh.2022.911107</elocation-id>
                        <fpage>911107</fpage>
                        <pub-id pub-id-type="pmid">36060608</pub-id>
                        <pub-id pub-id-type="doi">10.3389/fgwh.2022.911107</pub-id>
                    </mixed-citation>
                </ref>
                <ref id="rep-ref-33809-5">
                    <label>5</label>
                    <mixed-citation publication-type="journal">
                        <person-group person-group-type="author"/>:
                        <article-title>Testing a counseling message for increasing uptake of self-injectable contraception in southern Malawi: A mixed-methods, clustered randomized controlled study.</article-title>
                        <source>
                            <italic>PLoS One</italic>
                        </source>.<year>2022</year>;<volume>17</volume>(<issue>10</issue>) :
                        <elocation-id>10.1371/journal.pone.0275986</elocation-id>
                        <fpage>e0275986</fpage>
                        <pub-id pub-id-type="pmid">36256638</pub-id>
                        <pub-id pub-id-type="doi">10.1371/journal.pone.0275986</pub-id>
                    </mixed-citation>
                </ref>
            </ref-list>
        </back>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report35440">
        <front-stub>
            <article-id pub-id-type="doi">10.21956/gatesopenres.15637.r35440</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Ontiri</surname>
                        <given-names>Susan</given-names>
                    </name>
                    <xref ref-type="aff" rid="r35440a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-7622-5714</uri>
                </contrib>
                <aff id="r35440a1">
                    <label>1</label>International Centre for Reproductive Health Kenya, Mombasa, Mombasa County, Kenya</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>4</day>
                <month>12</month>
                <year>2023</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2023 Ontiri S</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport35440" related-article-type="peer-reviewed-article" xlink:href="10.12688/gatesopenres.14326.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>reject</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>Thank you for the opportunity to read this paper, entitled 
                <italic>Benefits, anxieties, acceptance, and barriers to the new injectable contraceptive DMPA-SC (Sayana Press): Clients&#x2019; perceptions in Sindh, Pakistan</italic>. The article focuses on the perspectives of clients on the newly introduced injectable contraceptive DMPA-SC in Sindh, Pakistan 
                <list list-type="bullet">
                    <list-item>
                        <p>The introductory section of the paper could be enhanced by providing more in-depth information on the rollout and implementation of DMPA-SC across the country. It would be helpful to elaborate on the extent to which this contraceptive method has been introduced and integrated into the country's family planning services both in the public and private to give readers a more comprehensive understanding of the context in which the research is being conducted. This information would also be crucial for interpreting the findings and assessing the relevance of the study's conclusions to the broader implementation of DMPA-SC in the country.</p>
                    </list-item>
                    <list-item>
                        <p>The paper's initial focus on DMPA IM is incongruous with its primary focus on DMPA SC. While presenting findings related to both methods could provide a valuable comparison, the paper's limited exploration of DMPA IM alongside DMPA SC hinders this potential comparison. A rationale of presenting the findings related to DMPA-IM should be provided. Otherwise, I would recommend limiting the findings to DMPA-SC given the topic of interest.</p>
                    </list-item>
                    <list-item>
                        <p>The results section, such as that on FP access, is occasionally combined with the discussion section. The results section should be limited to presenting the findings of the study,</p>
                    </list-item>
                    <list-item>
                        <p>The pricing structure for DMPA-SC requires clarification. Is the price solely associated with this method, or does it reflect the overall cost of FP services? The study's findings are disjointed, with some participants expressing a willingness to pay $1 in the private sector, but no information is provided on the pricing in the public sector. This needs to be unpacked considering that the paper was not focused on the private sector. In addition, in the introduction, the authors indicate that DMPA SC has only been rolled into the public sector. As such, one is unable to link the findings with the context.</p>
                    </list-item>
                    <list-item>
                        <p>The paper's failure to provide a comprehensive discussion section deprives the reader of a crucial opportunity to delve into the nuances of the findings, and compare with other existing literature on DMPA-SC and their potential impact on future research and practice.</p>
                    </list-item>
                    <list-item>
                        <p>My one methodological comment is that while a minimum of three focus group discussions (FGDs) can provide preliminary insights and identify key themes, additional interviews may be necessary to delve into more intricate or nuanced aspects of the research topic. The authors should explicitly acknowledge the limitations of their chosen methodology. The paper would have been strengthened by incorporating the perspectives of early adopters of DMPA-SC given that the study was conducted in a region that first rolled out DMPA-SC.</p>
                    </list-item>
                </list>
            </p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>Partly</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>Yes</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>No</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>Partly</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>No</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>Yes</p>
            <p>Reviewer Expertise:</p>
            <p>Public health-sexual and reproductive health</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons outlined above.</p>
        </body>
    </sub-article>
</article>
